سعر ميباكليند 300 مجم 8 كبسولات 2025

Clindamycin 300 mg oral capsules (Mepaco), pack of 8.

• Serious infections caused by susceptible anaerobic bacteria.Population: Adults and pediatric patientsDailyMed (U.S. National Library of Medicine)
• Serious infections due to susceptible streptococci, pneumococci and staphylococci in penicillin-allergic patients or when a penicillin is inappropriate.Population: Adults and pediatric patientsDailyMed (U.S. National Library of Medicine)

• Abdominal pain, nausea, vomiting, diarrhoea and pseudomembranous colitis; oesophagitis and oesophageal ulcer (especially when taken lying down or with little water); metallic taste; morbilliform rash.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• History of hypersensitivity to clindamycin or lincomycin.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Boxed warning: Clostridioides difficile-associated diarrhoea (CDAD), ranging from mild diarrhoea to fatal colitis, may occur during or up to 2 months after treatment; reserve clindamycin for serious infections where less toxic agents are inappropriate.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Severe hypersensitivity reactions including anaphylaxis and severe cutaneous reactions (SJS, TEN, DRESS) have been reported; discontinue if they occur.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Acute kidney injury has been reported; monitor renal function in patients with pre-existing renal dysfunction or nephrotoxic co-medication. Clindamycin does not diffuse adequately into cerebrospinal fluid and should not be used for meningitis.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Neuromuscular blocking agentsClindamycin may enhance the action of other neuromuscular blocking agents; use with caution.DailyMed (U.S. National Library of Medicine)
• Strong CYP3A4/3A5 inhibitors or inducersInhibitors may increase and inducers may reduce clindamycin concentrations; monitor for adverse reactions or loss of effectiveness.DailyMed (U.S. National Library of Medicine)

• Clindamycin appears in breast milk (<0.5-3.8 mcg/ml); not a reason to stop breastfeeding, but an alternative may be preferred; monitor the infant for diarrhoea, candidiasis or bloody stools.International label, same formulation · DailyMed (U.S. National Library of Medicine)

English text not available for this section.